Posts

Showing posts with the label Prurigo Nodularis (PN) competitive landscape

Prurigo Nodularis (PN) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Prurigo Nodularis (PN) is a skin disorder characterized by the formation of firm, itchy nodules on the skin's surface. The intense itching (pruritus) associated with PN often prompts individuals to scratch excessively, leading to bleeding or discomfort and potentially exacerbating the condition by inducing additional skin lesions. The underlying pathophysiology of PN has been a subject of debate, with chronic or recurrent mechanical trauma or vigorous frictional pressure believed to induce epidermal hyperplasia, resulting in skin thickening. Diagnosing Prurigo nodularis primarily relies on clinical observation. Patients typically present with a history of persistent and severe itching, along with excoriations and flesh-colored or pink nodular lesions predominantly on extensor surfaces. Dermoscopy can be a valuable diagnostic aid, particularly in distinguishing PN from other dermatological conditions. Various topical treatments are available for managing Prurigo nodularis, includin...

Prurigo Nodularis (PN) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Prurigo nodularis (PN) is a skin disease that causes hard, itchy lumps (nodules) to form on the skin. The itching (pruritus) can be intense, causing people to scratch themselves to the point of bleeding or pain. Scratching can cause more skin lesions to appear. ·        Prurigo nodularis (PN) is a relatively rare condition, with an estimated prevalence of 72 per 100,000 in an epidemiologic study of US adults aged 18 to 64 years with healthcare insurance. Thelansis’s “Prurigo Nodularis (PN) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Prurigo Nodularis (PN) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and ...

Prurigo Nodularis (PN) – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Image
  Prurigo Nodularis (PN) is a skin disease that causes hard, itchy lumps (nodules) to form on the skin. The itching (pruritus) can be intense, causing people to scratch themselves to the point of bleeding or pain. Scratching can cause more skin lesions to appear.   Etiology- The exact cause of Prurigo Nodularis (PN) is not well-understood.   Epidemiology- PN is a relatively rare condition, with an estimated prevalence of 72 per 100,000 in an epidemiologic study of US adults aged 18 to 64 years with healthcare insurance.   The competitive landscape of Prurigo Nodularis (PN) includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Prurigo Nodularis (PN) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment lands...